BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McLean LS, Faisal W, Parakh S, Kao SC, Lewis CR, Chin MT, Voskoboynik M, Itchins MJ, Jennens RR, Broad AR, Morris TA, Solomon BJ. Standard-Dose Osimertinib in EGFR-Mutated Non-Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease. JCO Precis Oncol 2021;5:561-8. [PMID: 34994604 DOI: 10.1200/PO.20.00464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 . Osimertinib. Reactions Weekly 2022;1905:406-406. [DOI: 10.1007/s40278-022-14796-4] [Reference Citation Analysis]